IPO Issue Details
Issue Price / Price Band₹54 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size2,000 Shares per Lot
Total Issue Size41,32,000 shares (aggregating up to ₹22.31 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenWed, 10 Sep 2025
Subscription CloseFri, 12 Sep 2025
Anchor AllotmentTue, 09 Sep 2025
Basis of AllotmentMon, 15 Sep 2025
Initiation of RefundsTue, 16 Sep 2025
Credit of Shares to DematTue, 16 Sep 2025
Listing DateWed, 17 Sep 2025
UPI Mandate Deadline2025-09-12
Application & Investment Details
Retail — Min (2 Lots)₹2,16,000 — 4000 shares
Retail — Max (13 Lots)₹1,404,000 (13 Lots)
HNI — Min (3 Lots)₹3,24,000 — 6000 shares
EPS (Pre-IPO)₹2.84
EPS (Post-IPO)₹2.22
P/E Ratio (Pre-IPO)19.01x
P/E Ratio (Post-IPO)24.31x
Net Offer to Public39,24,000 shares (aggregating up to ₹21.19 Cr)
Reserved for Market Maker2,08,000 shares (aggregating up to ₹1.12 Cr)
Pre-IPO Promoter Holding1,18,63,983 shares
Post-IPO Promoter Holding1,51,71,983 shares
Fresh Issue Shares31,00,000 shares (aggregating up to ₹16.74 Cr)
Offer for Sale Shares8,24,000 shares of ₹10 (aggregating up to ₹4.45 Cr)
About Galaxy Medicare Ltd.
Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.The company manufactures these products using premium grade raw material that is procured from the authentic vendors of the market.The company specializes in various products, including surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, and wound care solutions.Their offerings meet diverse medical needs, including gauze products and orthopedic items.The company's business includes the following:-Manufacturing and branding for flagship brands: POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, FIXCAN ETC.;OEMs source components, design, manufacture, and test quality according to brand owners' specifications under Principal-to-Principal basis;Institutional sales via government tenders on GEM Portal;Exporting its products internationally and trading surgical devices dressings.The company has 27 registered trademarks in India, serving domestic and international markets.The company's products are accepted by the medical community and supplied throughout India to government health departments, corporate hospitals, and private entities.The company complies with ISO 9001:2015 and ISO 13485:2016 certifications, ensuring that its products meet the rigorous demands of healthcare institutions.As of March 2025, the company has 190 employees in various departments.Competitive Strength:Experienced Leadership and Skilled Management Team.Established reputation and customer relationships.Focus on consistently meeting quality standards.Well Established Manufacturing Facility with Wide Range of Products.In-house Quality Assurance (QA) / Quality Control (QC) and Research & Development for quality control.International market Presence.
Objects of the Issue
Galaxy Medicare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 . Funding Capital Expenditure requirement towards purchase of machinery for the existing manufacturing facility at Bhubaneshwar, Odisha
4.89
2
2 Funding the working capital requirements
8.94
3
3 General Corporate Purposes
2.25
4
4 To meet the offer related expenses
1.79
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,18,63,983 shares
Post-IPO Promoter Holding
1,51,71,983 shares